ATP5F1D and Disorder of energy metabolism: This result is in line with the reports regarding the effect of some QSYQ ingredients, such as ginsenoside Rb1 and R1, which were shown able to inhibit RhoA/ROCK meanwhile elevate ATP5D expression and ATP level (He et al., 2014; Cui et al., 2017), protecting I/R-induced energy metabolism disorder.